Regulatory T cells and cancer: an undesired tolerance

Slides:



Advertisements
Similar presentations
Waging War on Cancer with the Sword of Immunity Cell Volume 158, Issue 2, (July 2014) DOI: /j.cell Copyright © 2014 Terms and Conditions.
Advertisements

Volume 88, Issue 5, Pages (November 2015)
Michael D. Gautreaux, Barry I. Freedman  Kidney International 
Plasma sodium and hypertension
Anemia management in chronic kidney disease
Volume 83, Issue 3, Pages (March 2013)
Germaine Wong, Jeremy R. Chapman, Jonathan C. Craig 
Stem cells for kidney repair: useful tool for acute renal failure?
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
Inactivation of Stat3 in tumor cells
It Takes Two to Tango Immunity
Volume 86, Issue 1, Pages (July 2014)
Volume 70, Issue 7, Pages (October 2006)
Reassessment of the care of the patient with chronic kidney disease
Volume 80, Issue 10, Pages (November 2011)
John P. Middleton, Patrick H. Pun  Kidney International 
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?  Fu L. Luan, Diane E. Steffick,
Metformin and other antidiabetic agents in renal failure patients
Volume 84, Issue 2, Pages (August 2013)
Methotrexate in the urine
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
Maria A. Curotto de Lafaille, Juan J. Lafaille  Immunity 
Volume 73, Issue 7, Pages (April 2008)
Nephrology Crosswords: Hemodialysis
Volume 86, Issue 2, Pages (August 2014)
Harnessing regulatory T cells for therapeutic purposes
The calcium–phosphorus in guidelines for CKD-MBD
Volume 88, Issue 4, Pages (October 2015)
David Del Bello, Michael J. Ross, Shirish S. Huprikar 
Blood pressure targets in hemodialysis patients
Frank Eitner, Jürgen Floege  Kidney International 
Volume 84, Issue 4, Pages (October 2013)
Volume 75, Issue 11, Pages (June 2009)
Volume 85, Issue 3, Pages (March 2014)
A physician's perseverance uncovers problems in a key nephrology study
Low oxygen stimulates the immune system
Can we prevent donor-specific antibodies from developing after ABO-incompatible kidney transplantation?  Lionel Rostaing, Nassim Kamar  Kidney International 
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 74, Issue 8, Pages (October 2008)
Volume 87, Issue 3, Pages (March 2015)
Alternate-day dialysis may be needed for hemodialysis patients
Nephrology Crossword: Peritoneal Dialysis
Volume 85, Issue 1, Pages 3-4 (January 2014)
Nephrology Crossword: Glomerulonephritis
Volume 80, Issue 3, Pages (August 2011)
A man with a hole in his penis
Volume 87, Issue 5, Pages (May 2015)
Mediterranean diets: are they practical in the Western world?
Volume 82, Issue 9, Pages (November 2012)
Organ transplantation goes to the movies
Volume 76, Issue 12, Pages (December 2009)
Volume 83, Issue 4, Pages (April 2013)
The hypothesis that abnormal BH4 metabolism impairs kidney function
Volume 76, Issue 1, Pages 8-10 (July 2009)
Volume 70, Issue 3, Pages (August 2006)
The Case ∣ A female with hyponatremia
Volume 70, Issue 5, Pages (September 2006)
Kathryn J. Wiggins, Darren J. Kelly  Kidney International 
Volume 75, Issue 7, Pages (April 2009)
Dana V. Rizk, David G. Warnock  Kidney International 
Hisataka Kobayashi, Peter L. Choyke  Kidney International 
The international realities of live donor kidney transplantation
Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga 
Volume 88, Issue 6, Pages (December 2015)
Volume 70, Issue 6, Pages (September 2006)
Online blogging during conferences: an innovative way of e-learning
Ronen Levi, Justin Silver  Kidney International 
Presentation transcript:

Regulatory T cells and cancer: an undesired tolerance Didier Ducloux  Kidney International  Volume 86, Issue 1, Pages 16-18 (July 2014) DOI: 10.1038/ki.2014.46 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 Defect in cancer immune surveillance in transplant patients. Both immunosuppressive drugs and an increase in tumor-driven Tregs (i.e., migration and expansion of naturally occurring Tregs (nTregs) or conversion and expansion of induced Tregs (iTregs)) contribute to impair immune responses against cancer in transplant patients. Therapeutic approaches should target both mechanisms. CNI, calcineurin inhibitor; mTORi, mTOR inhibitor; NK, natural killer; Treg, regulatory T cell. Kidney International 2014 86, 16-18DOI: (10.1038/ki.2014.46) Copyright © 2014 International Society of Nephrology Terms and Conditions